Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 02:40PM ET
35.95
Dollar change
+0.18
Percentage change
0.51
%
Index- P/E22.91 EPS (ttm)1.57 Insider Own2.50% Shs Outstand285.78M Perf Week0.06%
Market Cap10.27B Forward P/E21.90 EPS next Y1.64 Insider Trans-9.45% Shs Float278.45M Perf Month3.40%
Income466.92M PEG0.70 EPS next Q0.39 Inst Own87.76% Short Float2.84% Perf Quarter42.95%
Sales2.08B P/S4.93 EPS this Y154.84% Inst Trans2.26% Short Ratio3.73 Perf Half Y62.09%
Book/sh7.96 P/B4.52 EPS next Y-0.91% ROA15.73% Short Interest7.90M Perf Year64.39%
Cash/sh4.16 P/C8.63 EPS next 5Y32.96% ROE20.20% 52W Range19.20 - 36.97 Perf YTD49.86%
Dividend Est.- P/FCF23.73 EPS past 5Y-21.77% ROI18.90% 52W High-2.76% Beta0.52
Dividend TTM- Quick Ratio3.88 Sales past 5Y17.31% Gross Margin96.25% 52W Low87.25% ATR (14)0.85
Dividend Ex-Date- Current Ratio3.93 EPS Y/Y TTM462.64% Oper. Margin29.22% RSI (14)63.94 Volatility2.36% 2.28%
Employees1310 Debt/Eq0.09 Sales Y/Y TTM17.31% Profit Margin22.43% Recom1.91 Target Price32.67
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q12163.64% Payout0.00% Rel Volume0.46 Prev Close35.77
Sales Surprise10.04% EPS Surprise17.89% Sales Q/Q14.33% EarningsOct 29 AMC Avg Volume2.12M Price35.95
SMA201.19% SMA5014.57% SMA20041.84% Trades Volume781,358 Change0.51%
Date Action Analyst Rating Change Price Target Change
Oct-16-24Reiterated RBC Capital Mkts Outperform $30 → $34
Sep-19-24Initiated UBS Neutral $30
Apr-11-24Downgrade Barclays Overweight → Equal Weight $25
Dec-19-23Initiated BTIG Research Buy $27
Dec-15-23Initiated Citigroup Buy $31
Sep-26-23Initiated H.C. Wainwright Buy $28
Aug-22-23Reiterated Oppenheimer Outperform $25 → $29
Aug-08-23Initiated SVB Securities Market Perform $18
Jul-11-23Resumed Morgan Stanley Equal-Weight $21
May-10-23Resumed Piper Sandler Overweight $28
Nov-29-24 09:50AM
Nov-28-24 11:31AM
Nov-27-24 04:05PM
Nov-26-24 04:05PM
Nov-25-24 09:40AM
12:45PM Loading…
Nov-21-24 12:45PM
Nov-11-24 02:06PM
12:00PM
09:50AM
Nov-07-24 04:05PM
09:40AM
Nov-05-24 12:45PM
12:20PM
Nov-04-24 09:15AM
Nov-03-24 06:41AM
07:00PM Loading…
Oct-31-24 07:00PM
07:29AM
Oct-30-24 11:40AM
03:15AM
02:51AM
12:00AM
Oct-29-24 06:30PM
05:20PM
04:20PM
04:05PM
Oct-24-24 09:50AM
Oct-23-24 12:00PM
09:53AM
Oct-22-24 10:01AM
Oct-21-24 09:40AM
11:01AM Loading…
Oct-16-24 11:01AM
Oct-15-24 04:05PM
01:57PM
07:39AM
Oct-14-24 08:00AM
Oct-09-24 08:30AM
Sep-26-24 08:45AM
Sep-20-24 09:50AM
Sep-16-24 09:40AM
09:13AM
08:45AM
Sep-15-24 08:45AM
Sep-14-24 07:39PM
Sep-05-24 11:31AM
Sep-02-24 09:50AM
Aug-29-24 09:40AM
Aug-28-24 04:05PM
Aug-26-24 12:20PM
Aug-17-24 01:01AM
Aug-16-24 08:09AM
Aug-13-24 09:44AM
Aug-12-24 09:15AM
Aug-11-24 09:31PM
Aug-09-24 10:28AM
07:35AM
Aug-07-24 02:29PM
01:30PM
07:46AM
01:15AM
Aug-06-24 06:30PM
05:35PM
04:27PM
04:05PM
08:30AM
Aug-05-24 09:16AM
Jul-30-24 10:01AM
Jul-23-24 04:05PM
Jul-09-24 06:00AM
Jun-27-24 03:28PM
Jun-24-24 09:07PM
Jun-07-24 03:01AM
May-31-24 01:58PM
May-30-24 11:31AM
May-28-24 04:05PM
May-24-24 02:34AM
May-21-24 11:20AM
May-20-24 09:22AM
08:00AM
May-14-24 07:04PM
07:52AM
May-12-24 01:25PM
May-09-24 03:48PM
May-08-24 10:30AM
May-07-24 04:05PM
May-06-24 12:10PM
May-03-24 12:21PM
May-02-24 03:33PM
May-01-24 11:15AM
09:14AM
07:39AM
03:35AM
12:00AM
Apr-30-24 08:57PM
06:30PM
05:35PM
05:26PM
04:19PM
04:05PM
Apr-27-24 07:00AM
Apr-16-24 04:05PM
Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hessekiel JeffreyEVP & General CounselNov 27 '24Option Exercise18.80129,3142,431,103644,967Dec 02 08:29 PM
Hessekiel JeffreyEVP & General CounselNov 29 '24Sale36.6760,0002,200,200486,059Dec 02 08:29 PM
JEFFREY HESSEKIELOfficerNov 29 '24Proposed Sale36.6760,0002,200,230Nov 29 01:12 PM
Haley Patrick J.EVP, CommercialNov 22 '24Sale35.2710,000352,700278,665Nov 26 07:05 PM
PATRICK JOSEPH HALEYOfficerNov 22 '24Proposed Sale35.2710,000352,700Nov 22 04:01 PM
Haley Patrick J.EVP, CommercialNov 18 '24Sale34.3641,5881,428,822288,665Nov 19 08:03 PM
Haley Patrick J.OfficerNov 18 '24Proposed Sale34.4119,381666,974Nov 18 06:50 PM
PATRICK JOSEPH HALEYOfficerNov 18 '24Proposed Sale34.3122,207761,884Nov 18 04:10 PM
Aftab DanaCSO/EVP Disc & Trans ResearchNov 05 '24Option Exercise18.8096,9861,823,337595,931Nov 07 07:44 PM
Aftab DanaCSO/EVP Disc & Trans ResearchNov 05 '24Sale35.0096,9863,394,510498,945Nov 07 07:44 PM
Hessekiel JeffreyEVP & General CounselNov 01 '24Sale34.1350,0001,706,500530,325Nov 05 07:05 PM
POSTE GEORGEDirectorNov 01 '24Sale34.0030,0001,020,000169,020Nov 05 07:04 PM
DANA T AFTABOfficerNov 05 '24Proposed Sale35.0096,9863,394,510Nov 05 04:23 PM
Aftab DanaCSO/EVP Disc & Trans ResearchOct 30 '24Sale31.401,16236,487498,945Nov 01 06:43 PM
POSTE GEORGEDirectorNov 01 '24Proposed Sale34.0030,0001,020,112Nov 01 04:54 PM
JEFFREY J HESSEKIELOfficerNov 01 '24Proposed Sale33.2025,000830,000Nov 01 04:47 PM
Hessekiel JeffreyEVP & General CounselOct 28 '24Sale28.3925,000709,750580,325Oct 30 06:04 PM
DANA T AFTABOfficerOct 30 '24Proposed Sale31.401,16236,487Oct 30 04:10 PM
Haley Patrick J.EVP, CommercialOct 02 '24Option Exercise24.41100,0002,441,000441,036Oct 03 09:22 PM
MORRISSEY MICHAELPresident and CEOOct 01 '24Option Exercise24.41480,00011,716,8001,444,384Oct 03 09:22 PM
Hessekiel JeffreyEVP & General CounselSep 23 '24Sale26.3825,000659,500605,325Sep 25 07:32 PM
JEFFREY J HESSEKIELOfficerSep 23 '24Proposed Sale26.4275,0001,981,500Sep 23 04:24 PM
Hessekiel JeffreyEVP, General Counsel & SecAug 26 '24Option Exercise24.4120,000488,200650,325Aug 28 07:07 PM
Hessekiel JeffreyEVP, General Counsel & SecAug 26 '24Sale25.7920,000515,800630,325Aug 28 07:07 PM
Freire Maria CDirectorAug 14 '24Sale26.568,250219,12091,007Aug 16 07:35 PM
Aftab DanaCSO/EVP Disc & Trans ResearchAug 12 '24Sale27.0620,883565,094500,107Aug 14 07:12 PM
MARIA C FREIREDirectorAug 14 '24Proposed Sale26.568,250219,122Aug 14 05:01 PM
POSTE GEORGEDirectorAug 08 '24Sale26.8933,725906,865199,020Aug 12 07:22 PM
Aftab DanaCSO/EVP Disc & Trans ResearchAug 07 '24Option Exercise24.4195,0002,318,950615,990Aug 09 07:32 PM
Aftab DanaCSO/EVP Disc & Trans ResearchAug 07 '24Sale25.0095,0002,375,000520,990Aug 09 07:32 PM
Haley Patrick J.EVP, CommercialAug 07 '24Sale25.5014,000357,000341,036Aug 09 07:32 PM
Hessekiel JeffreyEVP, General Counsel & SecAug 07 '24Option Exercise24.4180,0001,952,800710,325Aug 09 07:32 PM
Hessekiel JeffreyEVP, General Counsel & SecAug 07 '24Sale25.9780,0002,077,600630,325Aug 09 07:32 PM
Senner Christopher J.EVP and CFOAug 09 '24Option Exercise24.41125,0003,051,250846,680Aug 09 07:31 PM
Senner Christopher J.EVP and CFOAug 09 '24Sale27.19125,0003,398,750721,680Aug 09 07:31 PM
Senner Christopher J.OfficerAug 09 '24Proposed Sale27.17125,0003,396,250Aug 09 05:20 PM
Aftab DanaOfficerAug 09 '24Proposed Sale27.2520,883569,062Aug 09 05:18 PM
POSTE GEORGEDirectorAug 08 '24Proposed Sale26.8933,725906,746Aug 08 05:42 PM
DANA T AFTABOfficerAug 07 '24Proposed Sale25.0095,0002,375,000Aug 07 04:17 PM
JEFFREY J HESSEKIELOfficerAug 07 '24Proposed Sale23.45100,0002,345,000Aug 07 04:13 PM
PATRICK JOSEPH HALEYOfficerAug 07 '24Proposed Sale25.5014,000357,000Aug 07 04:11 PM
WYSZOMIERSKI JACK LDirectorJun 04 '24Sale22.008,287182,314349,499Jun 06 08:37 PM
JOHNSON DAVID EDWARDDirectorMay 30 '24Buy20.76225,0004,670,0551,525,730May 30 07:50 PM
JOHNSON DAVID EDWARDDirectorMay 28 '24Buy20.32200,0004,063,9001,300,730May 30 07:50 PM
Smith JulieDirectorMay 21 '24Sale21.1227,280576,1545,445May 23 06:55 PM
POSTE GEORGEDirectorMay 21 '24Option Exercise19.5711,686228,695225,593May 22 07:23 PM
POSTE GEORGEDirectorMay 21 '24Sale20.9611,686244,939213,907May 22 07:23 PM
PAPADOPOULOS STELIOSDirectorMay 20 '24Option Exercise19.5711,686228,6951,272,015May 22 07:23 PM
PAPADOPOULOS STELIOSDirectorMay 20 '24Sale21.0011,437240,1771,260,578May 22 07:23 PM
WYSZOMIERSKI JACK LDirectorMay 13 '24Option Exercise19.5711,686228,695349,871May 15 07:44 PM
WYSZOMIERSKI JACK LDirectorMay 13 '24Sale21.3710,923233,425338,948May 15 07:44 PM
Garber Alan MDirectorMar 21 '24Option Exercise19.5723,491459,71954,908Mar 25 07:31 PM
Garber Alan MDirectorMar 21 '24Sale24.0119,205461,11235,703Mar 25 07:31 PM
Haley Patrick J.EVP, CommercialFeb 23 '24Sale21.4547,0201,008,579384,866Feb 27 06:58 PM
JOHNSON DAVID EDWARDDirectorFeb 21 '24Buy20.70190,0003,932,7341,100,730Feb 22 05:08 PM
Haley Patrick J.EVP, CommercialDec 14 '23Option Exercise16.2950,000814,500357,687Dec 14 07:56 PM
Haley Patrick J.EVP, CommercialDec 14 '23Sale23.3550,0001,167,500307,687Dec 14 07:56 PM
Haley Patrick J.EVP, CommercialDec 12 '23Sale22.5014,149318,352307,687Dec 14 07:56 PM
Hessekiel JeffreyEVP, General Counsel & SecDec 13 '23Sale23.0125,000575,250533,345Dec 14 07:55 PM